semaj83/ctmatch_classification huggingface dataset:
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Contrast Induced Nephropathy All adult patients (18 years and above) who are scheduled for cardiac catechization and have abnormal but stable renal function will be eligible for enrollment. Abnormal renal function is defined as a creatinine level exceeding the normal range (more than 115 or 96 um/L in males and females, respectively, in KFSH&RC laboratories) or eGFR less than 60 ml/min  Patients who fall under any of the following categories will be excluded Acute renal failure Cardiogenic shock Emergency cardiac catheterization Preexisting peritoneal or hemodialysis Pregnancy Recent exposure to contrast agent within the last 3 days Allergy to contrast or any of the above treatment Renal transplant Patients who received dopamine, mannitol, theophyllin or other medications known to affect renal function within one week from cardiac cath
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 16.0-26.0,  Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papillomavirus Infection Females between 16 to 26-years-old Has never had Pap testing or has only had normal Pap test results Lifetime history of 0 to 4 sexual partners  History of an abnormal cervical biopsy result History of a positive test for HPV; History of external genital/vaginal warts Currently a user of illegal drugs or an alcohol abuser History of severe allergic reaction that required medical attention Are pregnant Received a marketed HPV vaccine Currently enrolled in a clinical trial Currently has or has a history of certain medical conditions or is currently taking or has taken certain medications (details will be discussed at the time of consent)
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 30.0-999.0,  Human Papillomavirus Clearance at 12 Months Biopsy-confirmed LSIL patients Age more than 30 years-old Baseline HPV testing is positive Be able to give their informed consent to this study  Having active cervical infection Having lesion of 2 mm-larger than probe Having lesion inside cervical os Having suspected cervical cancer lesion
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cardiovascular Disease de Novo Coronary Lesions Appropriate Patient Patient is eligible to receive a Boston Scientific TAXUS Stent Inappropriate Patient Known sensitivity to paclitaxel Known allergy to stainless steel Patients in whom antiplatelet and / or anticoagulant therapy is contraindicated Patients judged to have a lesion that prevents complete inflation of an angioplasty balloon or proper placement of the stent or delivery device Patients with unresolved vessel thrombus at the lesion site Patients with coronary artery reference vessel diameters less than 2.5 mm or greater than 3.75 mm Patients with lesions located in the left main coronary artery, ostial lesions, or lesions located at a bifurcation Patients with diffuse disease or poor overflow distal to the identified lesions
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Breast Lesion Patient needs to be ≥ or = to 18 years of age scheduled for diagnostic breast MRI examination or interventional procedure for a suspected or known breast lesion ≥ or = to 1 centimeter  Patients who would be normally excluded from undergoing an MRI examination Patients with a pacemaker, aneurysm clip or any other condition that would warrant avoidance of a strong magnetic field Patients who are pregnant are excluded from participation of this study Patients who are unable to comply or complete the MRI exam due to claustrophobia or high levels of anxiety Patients undergoing chemotherapy
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Healthy Be a cooperative, healthy male or female between the ages of 18-75 inclusive. 2. Have a physical examination which reveals no clinically significant abnormalities at the screening visit. 3. Have fewer than 6 gastric or duodenal erosions visible on nasal endoscopy at Visit 2. 4. If the subject is female and of childbearing potential, she has been using effective contraception since the last date of her menses, will continue to use effective contraception during the study period, is not breast-feeding or lactating at screening and has had a negative urine pregnancy test at screening. Women who have been post-menopausal for less than 2 years will also require a urine pregnancy test at screening. 5. Have provided written informed consent prior for admission to this study. 6. H. pylori negative serologic exam prior to baseline nasal EGD  Active GI disease (e.g. IBD), or a history of GI ulcers or bleeding 2. History of gastric or intestinal surgery 3. Use of ASA, NSAIDs, coxibs, or acetaminophen at any dose within 2 weeks prior to the randomization visit of the study. 4. Positive FOBT at baseline. 5. Use of over-the-counter or prescription: sucralfate, antacids, H2-receptor antagonists, misoprostol, or proton pump inhibitors 4 weeks prior to enrollment and/or during the study 6. A known allergy to the topical anesthetic, lidocaine
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer Precancerous Condition Included subjects will be ≥18 years old Included subjects will not be pregnant Included subjects will have a negative urine pregnancy test Included subjects will be scheduled for colposcopy and/or LEEP treatment at the VGH Women's Clinic Included subjects will indicate understanding of the study Included subjects will provide informed consent to participate  Individuals <18 years old will be excluded Pregnant individuals will be excluded Individuals that have had an operation to remove their cervix will be excluded
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-42.0,  Healthy Aged 18 years old and able to give voluntary written informed consent Willing to complete a daily log of mood symptoms for 3 consecutive menstrual cycles Be off of OCPs for at least 3 menstrual periods prior to beginning the study and be willing to go on OCPs for the study Provide documentation of a normal PAP smear, pelvic and breast examination within the previous 12 months prior to enrollment Have regular menstrual cycles 28 to 32 days in length prior to enrollment. The screening cycle must be ovulatory as confirmed by plasma progesterone levels of >3 ng/ml during the luteal phase Negative pregnancy blood test at admission; negative urine pregnancy test on the MRS testing day  Presence of any DSM-IV Axis I disorder, excepting possible mild to moderate PMS/PMDD, within the previous 12 months Lifetime history of any psychotic disorder, including bipolar disorder Meeting DSM-IV for psychoactive substance (including nicotine) abuse/dependence within the preceding 6 months A history of serious medical or neurological illness, including (but not limited to) major cardiovascular disease, hypertension (SBP > 140 mm Hg and DBP > 90 mm Hg), intracranial mass lesions, seizure disorder, severe hepatic or renal disease, unstable endocrine or metabolic disease, unstable hematologic disease, gynecologic cancer and gallbladder disease, venous thromboembolism, and stroke Diabetes if present with one other cardiovascular risk factor such as hypercholesterolemia or hypertension Hypercholesterolemia if LDL > 160 mg/dl Use of any psychotropic medication within the previous month Alcohol consumption greater than 7 drinks/week Current pregnancy or planning to become pregnant during the course of the study Metallic implants
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-64.0,  Cervical Cancer Female presenting to clinic for a Pap test for any reason  Pregnant Prisoners Mentally unable to provide informed consent
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Cervical Intraepithelial Neoplasia The women whose last one FCV of screening put in evidence a LIEBG of the neck of the womb having been confirmed by the colposcopie The inclusive patients will be of more than 18 years old. All the patients will be profitable of a regime of Social Security  The patients whose result of the colposcopie is clashing with that of the FCV of initial screening (normal collar, LIEHG or the other one) The patients having an antecedent of DREGS of the neck of the womb, that this one was or not handled The patients having had a hysterectomy The patients incapable to receive the information enlightened on the progress and the objectives of the study The patients not having signed enlightened assent
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cardiovascular Surgery With Coronary Angiography Males and females 18 years of age or older Undergoing angiographic procedure involving the intra-arterial administration of iodinated contrast agent(s) Chronic kidney disease indiacated by an eGFR < 75 ml/min/1.73 m2 based on screening labs performed ≤ 3 months prior to procedure Able and willing to provide written informed consent for study participation and to comply with all study procedures  Renal transplant recipients Pre-existing evidence of acute renal failure at the time of enrollment Already receiving dialysis (either acute or chronic) or in imminent need of dialysis at enrollment Coronary artery bypass surgery or PCI within the previous 30 days Participation in an interventional clinical study with an experimental therapy within the previous 30 days Administration of intravasular contrast within the previous 30 days Undergoing renal artery stenting
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Aids-related Malignancies Lymphoma Precancerous Condition Sarcoma Serologic documentation of HIV infection by any FDA-approved tests Enrolled in an AIDS Malignancy Clinical Trials Consortium (AMC) clinical trial of any new or existing pharmacotherapeutic agent for treatment of disease other than human papillomavirus (HPV)-associated neoplasia AMC study must have an accrual target of > 15 patients ECOG performance status (PS) 0-1 OR Karnofsky PS 60-100% Life expectancy ≥ 3 months Not pregnant or nursing Patients receiving myelosuppressive therapy must meet the following ANC > 1,000/μL Platelet count > 50,000/μL Evaluated before treatment or completely recovered from their nadir
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 19.0-120.0,  Cervical Cancer Precancerous Condition Received care at the Health Departments in Alabama and with an abnormal pap result, including any of the following Atypical squamous cells of undetermined significance (ASCUS) ASCUS, cannot high-grade lesion (ASCUS-H) Low-grade squamous intraepithelial lesion High-grade squamous intraepithelial lesion Referred to University of Alabama at Birmingham (UAB) Highlands Clinic for further colposcopic examination by Ob/Gyn physicians Tested positive for human papilloma virus (HPV) 16 and diagnosed with ≤ cervical intraepithelial neoplasia (CIN) 1 lesions at the 0-month visit With or without concurrent infections with other HR (High Risk) HPV types (HPV 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68) Not diagnosed with true preneoplastic lesions of the cervix based on a colposcopically directed biopsy Not pregnant
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 19.0-999.0,  HPV Infections HPV positive  Negative for HPV
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Postoperative Nausea and Vomiting All of the following must be met for the potential subject to be eligible for participation: 1. The subject is a female scheduled to undergo ambulatory breast surgery performed under general anesthesia 2. The subject is expected to undergo general inhalation anesthesia. 3. The subject presents with two of the three following high-risk factors associated with PONV (must be in their medical history in order to be eligible) She is a non-smoker She has documented history of PONV and/or motion sickness She is expected to receive intra-operative and postoperative opioid. 4. The subject's American Society of Anesthesiologist physical status is ASA I-III 5. The subject is between18 to 65 years of age. 6. The subject is expected to be discharged from the hospital/surgical center on the same day as the surgery. 7. The subject has provided written informed consent to participate in the study. If any of the following  are met, the potential subject is NOT eligible for participation: 1. The subject has a history of allergic reaction to, intolerances of or contraindications for any of the study medications or required anesthetic agents. 2. The subject has received or is expected to receive any excluded preoperative drug within 48 hours prior to induction; or is expected to receive any excluded intra-operative or postoperative medications. 3. The subject is pregnant or lactating. (If the potential subject is pre-menopausal, a urine pregnancy test must be performed within 24 hours/1 day of study prior to the planned surgery time and confirmed negative in order for the potential subject to be enrolled). 4. The subject is taking warfarin. 5. The subject has a history of alcohol and/or drug abuse within 1 year of study medication, or has a positive screening or pre-study test for alcohol or drugs of abuse. 6. The subject is expected to require the use of a nasogastric tube postoperatively. 7. The subject has a diagnosed latex allergy. 8. The subject has used oral aprepitant (Emend®) within the last 30 days. 9. The subject has participated in a randomized study or has been exposed to any experimental drug within 30 days prior to enrollment of this study
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 15.0-85.0,  Quality of Life Cervical Cancer Cervical Intraepithelial Neoplasia Thai patients aged more than 15 years old Diagnosed of cervical intraepithelial neoplasia (CIN) or cervical cancer with pathological confirmation. If she has more than one diseases, the most severe will be considered as diagnosis Not suffered from confusion or reduced level of consciousness or unable to communicate
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer years and older Ability to speak and clearly understand English Female patients  No previous history of Cervical Cancer Treatment(LEEP,Laser,Cone etc.) Women who have had Pap smears within the previous 10 months Women under the age of 18 Women who are pregnant Inability to give informed consent in English
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Heart Failure Clinical indication for left and right heart catheterization Willing and able to provide informed consent Male or female 18 years of age or greater Symptomatic heart failure (≥ NYHA Class II) Ejection fraction ≤ 35% Patient is in sinus rhythm Patient is considered to be in suitable health in the opinion of the investigator, as determined by: o A pre-study physical examination with no clinical abnormalities which in the opinion of the investigator would preclude participation in the study other than physical symptoms or signs consistent with stable heart failure For female patients only: Post-menopausal or sterilized, or if she is of childbearing potential, she is not breastfeeding, her pregnancy test is negative, she has no intention to become pregnant for up to 90 days following the study, and she is using contraceptive drugs or devices  Acute myocarditis Hypertrophic, restrictive, or constrictive cardiomyopathy Congenital heart disease Known left ventricular thrombus Significant stenotic valvular disease (severe aortic stenosis, mitral stenosis) Poorly controlled hypertension (SBP > 180 mmHg) Pacemaker dependent ventricular rhythm Detectable troponin or CK-MB > ULN at any timepoint within 14 days of enrollment Acute coronary syndrome or revascularization procedure within 30 days of enrollment ≥ 50% stenosis of the left main coronary artery
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Papanicolaou Smear Subjects must be 18 years of age or older and able to consent for themselves. All women undergoing speculum examinations for the following list of reasons will be eligible for this study. No other reasons for speculum examinations will be eligible. Eligible reasons Pap smears during well woman examinations Pap smears during routine early pregnancy visit vaginal discharge vaginal bleeding sexually transmitted disease check
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 16.0-999.0,  Cystic Fibrosis Male or post-menopausal or surgically sterile female patients Have a clinical diagnosis of Cystic Fibrosis with lung function tests greater or equal to 40% of normal Have normal renal function  Lung transplant patients Significant liver disease Any other non-CF-related lung disease that may interfere with study assessments